7.73
price down icon1.65%   -0.13
after-market Dopo l'orario di chiusura: 7.71 -0.02 -0.26%
loading
Precedente Chiudi:
$7.86
Aprire:
$7.77
Volume 24 ore:
273.25K
Relative Volume:
1.82
Capitalizzazione di mercato:
$161.51M
Reddito:
-
Utile/perdita netta:
$-22.38M
Rapporto P/E:
-5.4823
EPS:
-1.41
Flusso di cassa netto:
$-15.54M
1 W Prestazione:
-2.77%
1M Prestazione:
-3.13%
6M Prestazione:
+18.02%
1 anno Prestazione:
+11.22%
Intervallo 1D:
Value
$7.67
$8.11
Intervallo di 1 settimana:
Value
$7.67
$8.21
Portata 52W:
Value
$4.44
$11.80

Nuvectis Pharma Inc Stock (NVCT) Company Profile

Name
Nome
Nuvectis Pharma Inc
Name
Telefono
360-837-7232
Name
Indirizzo
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-07
Name
Ultimi documenti SEC
Name
NVCT's Discussions on Twitter

Confronta NVCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NVCT
Nuvectis Pharma Inc
7.73 164.22M 0 -22.38M -15.54M -1.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-02 Iniziato Maxim Group Buy
2025-03-17 Iniziato Laidlaw Buy
2022-07-13 Iniziato Ladenburg Thalmann Buy

Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie

pulisher
Jul 24, 2025

What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Why Nuvectis Pharma Inc. stock is on top investor watchlistsExplosive capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Nuvectis Pharma Inc. Stock Analysis and ForecastHigh-yield investments - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Nuvectis Pharma Inc. stockDynamic profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Nuvectis Pharma Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

(NVCT) On The My Stocks Page - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 21, 2025

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - Yahoo.co

Jul 21, 2025
pulisher
Jul 15, 2025

How Nuvectis Pharma Inc. stock performs during market volatilityFree Growth Investment Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Nuvectis Pharma Inc. stock price move sharplyHigh Confidence Trade Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Nuvectis Pharma Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

When (NVCT) Moves Investors should Listen - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Nuvectis reports positive drug interaction study for cancer drug NXP900 By Investing.com - Investing.com Nigeria

Jul 08, 2025
pulisher
Jul 08, 2025

Nuvectis Pharma, Inc. Announces Successful Completion of A Drug-Drug Interaction Study in Healthy Volunteers - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies - GlobeNewswire

Jul 08, 2025
pulisher
Jul 02, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Purchased by Oppenheimer & Co. Inc. - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

(NVCT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Nuvectis Pharma (NASDAQ:NVCT) Lowered to “Sell” Rating by Wall Street Zen - Defense World

Jun 29, 2025
pulisher
Jun 25, 2025

Is Nuvectis Pharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 21, 2025

(NVCT) Proactive Strategies - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 20, 2025

Silicon Valley - FinancialContent

Jun 20, 2025
pulisher
Jun 18, 2025

Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Insider Stock Buying Of Nuvectis Pharma Delivers Return On US$2.19m Investment - simplywall.st

Jun 18, 2025
pulisher
Jun 13, 2025

Nuvectis Pharma Approves Proposals at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Sold by Two Sigma Investments LP - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Reduces Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

(NVCT) Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Invests $103,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect? - MSN

Jun 09, 2025
pulisher
Jun 04, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Invests $34,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

May 20, 2025
pulisher
May 16, 2025

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewswire

May 16, 2025

Nuvectis Pharma Inc Azioni (NVCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):